Success and failure of virus-specific T cell responses in hepatitis C virus infection
- PMID: 21894013
- DOI: 10.1159/000329807
Success and failure of virus-specific T cell responses in hepatitis C virus infection
Abstract
Hepatitis C virus (HCV) infection is only cleared in a minority of infected individuals, the majority of patients develop chronic infection. Chronic HCV infection potentially leads to liver fibrosis, cirrhosis and finally hepatocellular carcinoma. The host immune response is an important determinant in the outcome of HCV infection. Innate as well as adaptive cellular and humoral immune responses mediate important antiviral actions; however, virus-specific T cell responses appear to be most critical. Indeed, strong and multispecific CD4+ as well as CD8+ T cell responses are required for viral clearance. Interestingly, individuals who express certain HLA alleles (which are important for antigen presentation to CD4+ and CD8+ T cells) have a higher chance to clear the virus. The mechanisms of protection by HLA class I alleles such as HLA-B27 have been characterized recently. In most individuals, however, the HCV-specific immune response fails to clear the virus. Several mechanisms underlying this HCV-specific T cell failure have been identified. These include viral factors such as viral escape mutations and immunological factors such as the expression of inhibitory receptors, which lead to CD8+ T cell dysfunction. An in-depth understanding of the determinants of success or failure of the HCV-specific T cell response is critical for the development of prophylactic as well as therapeutic vaccination regimes against HCV. Here, we will discuss the virological and immunological determinants of HCV clearance and persistence.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.Hepatology. 2006 Mar;43(3):563-72. doi: 10.1002/hep.21049. Hepatology. 2006. PMID: 16496339
-
[Immunopathology of chronic liver diseases].Verh Dtsch Ges Pathol. 1995;79:186-97. Verh Dtsch Ges Pathol. 1995. PMID: 8600684 Review. German.
-
Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.J Med Virol. 2006 Sep;78(9):1190-7. doi: 10.1002/jmv.20680. J Med Virol. 2006. PMID: 16847959
-
Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection.Genes Immun. 2007 Apr;8(3):181-92. doi: 10.1038/sj.gene.6364368. Epub 2007 Jan 18. Genes Immun. 2007. PMID: 17230195 Review.
-
T cell response in hepatitis C virus infection.J Clin Virol. 2005 Feb;32(2):75-85. doi: 10.1016/j.jcv.2004.05.008. J Clin Virol. 2005. PMID: 15653409 Review.
Cited by
-
Human Mesenchymal Stem Cells Modified with the NS5A Gene of Hepatitis C Virus Induce a Cellular Immune Response Exceeding the Response to DNA Immunization with This Gene.Biology (Basel). 2023 May 30;12(6):792. doi: 10.3390/biology12060792. Biology (Basel). 2023. PMID: 37372076 Free PMC article.
-
Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development.Virus Evol. 2016 Sep 6;2(2):vew024. doi: 10.1093/ve/vew024. eCollection 2016 Jul. Virus Evol. 2016. PMID: 27774307 Free PMC article.
-
Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity.Int J Mol Sci. 2023 Dec 23;25(1):268. doi: 10.3390/ijms25010268. Int J Mol Sci. 2023. PMID: 38203436 Free PMC article. Review.
-
Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.Curr Ther Res Clin Exp. 2017 Apr 27;85:20-28. doi: 10.1016/j.curtheres.2017.04.006. eCollection 2017. Curr Ther Res Clin Exp. 2017. PMID: 29158855 Free PMC article.
-
Modulation of Immune Cell Subsets by Hepatitis C Virus and Antiviral Therapy in Early Virological Response HCV Genotype 4-Infected Patients with Compensated Liver Disease.Med Princ Pract. 2021;30(2):168-177. doi: 10.1159/000511783. Epub 2020 Sep 23. Med Princ Pract. 2021. PMID: 32966988 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials